Melanin-concentrating hormone (MCH) is a hypothalamic neuropeptide that is important in the regulation of energy homeostasis. MCH signals via a seven-transmembrane G protein-coupled receptor, which is coupled to G␣ i . This receptor was initially cloned in rat and human and designated SLC-1 because of its homology to the somatostatin receptor. In rat brain, it is expressed in a pattern that mirrors the previously described pattern of projections of MCH-immunoreactive fibers.
brain by in situ hybridization and have shown MCH-R to be expressed in diverse brain areas implicated in the regulation of feeding, body adiposity, and sensory integration of smell and gustatory inputs, including the hypothalamus [paraventricular nucleus (magnocellular part) and dorsomedial, ventromedial, and arcuate nucleus], areas of the olfactory pathway, and the nucleus of the solitary tract.
We also studied MCH-R regulation and found that MCH-R expression is increased 7-fold by 48-h fasting or genetic leptin deficiency (ob/ob mice) and is completely blunted by leptin administration. In contrast, MCH-R messenger RNA expression remains unaltered in genetic MCH deficiency. Our findings suggest that MCH-R constitutes a central target of leptin action in the mammalian brain. 
M ELANIN-CONCENTRATING HORMONE (MCH) is
a cyclic nonadecapeptide expressed in the mammalian hypothalamus (lateral hypothalamic area and zona incerta) with an important role in the regulation of food intake and energy balance (1) . MCH expression is increased by fasting in both C57BL/6J (control) mice and the leptindeficient ob/ob mice, which have elevated baseline MCH messenger RNA (mRNA) levels compared with controls (2, 3) . Acutely administered to rats by the intracerebroventricular route, MCH leads to a 2-fold increase in food intake (2, 4 -7) . Targeted ablation of the MCH gene leads to a lean phenotype (8) , whereas MCH overexpression leads to mild obesity (Ludwig, D., and E. Maratos-Flier, unpublished observations).
MCH is one of several hypothalamic neuropeptides, including neuropeptide Y (NPY), agouti-related peptide, and MSH, known to regulate energy homeostasis, which are also known to be regulated positively or negatively by leptin (9, 10) . Leptin administration to fasting mice blunts the fastinginduced rise of hypothalamic MCH and NPY mRNA (11) . Leptin administration to leptin-deficient ob/ob mice also leads to a significant decrease in NPY expression in the hypothalamus (12) . We have observed similar effects of leptin on MCH expression (Tritos, N., and E. Maratos-Flier, unpublished observations). In contrast, leptin stimulates POMC expression (13) . The potential ability of leptin to regulate expression of receptors for these peptides has not been examined.
MCH acts through a specific G protein-coupled receptor (MCH-R) that was initially identified as SLC-1 through its homology to somatostatin receptors (14) . The sequences of the human and rat receptor have been reported. MCH-R was found by Northern blot analysis to be expressed in brain, skeletal muscle, eye, and tongue. MCH-R activation is specific for MCH and leads to a decrease in cAMP levels and a calcium influx (14 -17) .
In the present study we cloned the mouse ortholog of MCH-R complementary DNA (cDNA), and we performed in situ hybridization histochemistry to characterize the distribution of MCH-R in the murine brain. We subsequently examined changes in MCH-R expression at different metabolic stages (fasting and genetic leptin deficiency) with or without leptin administration as well as in MCH deficiency. We found that MCH-R is expressed in areas of the brain that have been implicated in the integration of feeding behavior, such as the cerebral cortex. We have also shown that leptin acts as a negative regulator of MCH-R expression in the brain, whereas MCH per se has no obvious effect on MCH-R expression.
Materials and Methods

Isolation of mouse SLC-1 cDNA
Based on an alignment of the published sequences of rat and human SLC-1 (14, 17), we identified conserved regions of the gene that correspond to the intronless carboxyl-terminus end and used them to design the following specific oligonucleotides: R1, 5Ј-tcaggtgcctttgctttctgtcct-3Ј; R2, 5Ј-gcatagcccaagctgatggccg-3Ј; R3, 5Ј-gtgcgggtcaccctctttgtcc-3Ј; R4, 5Ј-gaaccagtagaggtcagtgtc-3Ј; F2, 5Ј-ttcatgatccaccagctcat-3Ј; F3, 5Ј-tggccaccctggtgatctgcct-3Ј; and F4, 5Ј-gacactgacctctactggttca-3Ј. Mouse genomic DNA was isolated from mouse (C57BL/6J) tail tissue (DNAeasy, QIAGEN, Hilden, Germany) and subjected to PCR amplification (Hot Start, QIAGEN) using all possible pairwise combinations of the above-described forward (F) and reverse (R) primers under the following thermocycling conditions: 15 min at 95 C; 35 cycles of 2 min at 94 C, 2 min at 55 C, and 2 min at 72 C; followed by a 10-min terminal extension at 72 C. The PCR amplification products were subsequently analyzed by electrophoresis on a 2% agarose gel. Several fragments of the expected size were amplified and subcloned into the PCRII-TOPO vector (TOPO TA Cloning, Invitrogen, San Diego, CA). Sequence analysis was performed using an ABI Prism 373 DNA sequencer (PE Applied Biosystems, Foster City, CA) and the DyeDeoxy Terminator Cycle Sequence method. Subsequently, we performed rapid amplification of 5Ј-and 3Ј-cDNA ends (RACE) extension using the mouse specific primers R1, R2, and F3, respectively, along with an adaptor primer. A mouse brain Marathon-Ready cDNA library (CLONTECH Laboratories, Inc., Palo Alto, CA) was the source of template for the PCR amplification under the following cycling conditions: 95 C for 15 min; 5 cycles of 2 min at 94 C, 2 min at 64 C, and 2 min at 72 C; followed by 5 cycles of 2 min at 94 C, 2 min at 62 C, and 2 min at 72 C; followed by 30 cycles of 2 min at 94 C, 2 min at 60 C, and 2 min at 72 C; followed by a 10-min terminal extension at 72 C. The amplified fragments were also subcloned into the Topo-PCRII vector, and their nucleotide sequences were determined as described above. A full-length mouse SLC-1 cDNA sequence was then constructed using all sequences obtained from the various cloned fragments, employing the Vector NT1 5.2 sequence analysis software (Infomax, North Bethesda, MD). Having obtained the full-length mouse SLC-1 cDNA sequence, a 5Ј-end mouse-specific primer was designed, F55 (5Ј-atggatctgcaagcctcgttgctgtccact-3Ј), and used with primer R11 for PCR amplification of the full-length mouse SLC-1 cDNA from a mouse brain Marathon Ready cDNA library. The PCR product was cloned into the PCRII-TOPO vector, and its nucleotide sequence was verified.
Quantitative RT-PCR
Animals were killed by CO 2 . Their organs were rapidly removed and immediately frozen in liquid N 2 , followed by long-term (Ͻ1 month) storage at (Ϫ80 C). RNA was extracted from frozen mouse tissues (Ϫ80 C) using the Ultraspec RNA isolation system (Biotecx, Houston, TX) according to manufacturer's instructions. One hundred nanograms of RNA were used in multiplex one-step RT, followed by 40 cycles of PCR amplification (95 C, 15 sec; 60 C, 1 min) in a 50-l reaction mixture (TaqMan One-Step RT-PCR mix, PE Biosystems) containing 900 nm of each MCH-R mouse-specific forward primer (5Ј-gccacctcctcgcacaa-3Ј) and reverse primer (5Ј-cttcaccacggcaaaaatgac-3Ј) and 250 nm MCH-R mouse-specific fluorescent-labeled probe (5ЈFAM-ctacatcaacatcatcatgccttcagtgtttggta-3ЈTAMRA) and glyceraldehyde-6-phosphate dehydrogenase (GAPDH)-specific primers and VIC-labeled probe (TaqMan Rodent GAPDH control reagents, PE Biosystems, Foster City, CA). Realtime amplification data were collected by an ABI Prism 7700 Sequence Detection System (PE Biosystems).
The design of optimal SLC-1 primers pair and probe was facilitated by the Primer Express Software (PE Biosystems). To exclude genomic DNA amplification, the sequence of the MCH-R forward primer was designed to span an intron splice site. Furthermore, all PCR amplification reactions were performed in the presence and the absence of reverse transcriptase. Samples were run in quadruplicate. The simultaneous amplification in the same reaction tube of a housekeeping gene (GAPDH) was used to control for RNA input and integrity as well as efficiency of the amplification reaction.
Animals
Adult (20 -24 wk) male (25-30 g) C57BL/6J mice and obese ob/ob mice (45-55 g) were maintained at a 12-h light, 12-h dark cycle and constant temperature (22 C), and were allowed chow food (Purina mouse chow) and water ad libitum. In experiments involving fasting, C57BL/6J mice were either fasted for 48 h or kept on chow diet. Fasted mice were treated with either leptin (1 g/g, ip, twice daily) or saline. Control mice received saline injections as well. In experiments involving ob/ob mice, fed ob/ob animals were treated with either leptin (1 g/g, ip, twice daily) or saline for 48 h and control C57BL/6J mice were treated with saline. The generation of the MCH knockout (MCH-KO) mice has been described previously (8) , and the animals have now been backcrossed to the C57BL/6J background for six generations. The study protocol was approved by the animal use review committee at the Joslin Diabetes Center.
In situ hybridization histochemistry
Animals were killed 2 h into the onset of the light cycle. Mice were anesthetized with sodium pentobarbital (90 mg/kg, ip) and perfused transcardially with 20 ml saline and 50 ml 10% neutral buffered formalin (Accustain, Sigma, St. Louis, MO). Brains were removed, postfixed in 10% formalin for 4 h, and cryoprotected in 20% sucrose in PBS for at least 24 h. The brain tissue was subsequently frozen in dry-ice, and coronal sections (30 m thick) were obtained using a sliding microtome (AO Instrument Co, Buffalo, NY). In situ hybridization histochemistry was performed as previously described. Briefly, brain slices were mounted on glass slides, postfixed, acetylated, ethanol dehydrated, and stored at Ϫ20 C until hybridization. Antisense riboprobes were synthesized using a commercially available in vitro transcription kit (Promega Corp., Madison, WI). Sections were hybridized with the appropriate riboprobe in hybridization buffer in an air oven (57 C) for 18 h as described previously. Tissue sections were subsequently ribonuclease A-treated, washed, ethanol-dehydrated, air-dried, and exposed to Biomax MR film (Eastman Kodak Co., Rochester, NY) for 5-7 days. Slides were subsequently dipped in NTB-2 emulsion (Kodak), exposed at 4 C for 4 weeks, developed, counterstained with thionin, dehydrated in graded ethanol series, and coverslipped.
The absorbance of the autoradiographic images was measured by using a computing densitometer (Molecular Dynamics, Inc.) and the ImageQuant software (Molecular Dynamics, Inc.). The intensity of the hybridization signal in specific brain regions was also estimated by counting silver granules in microscopic images with the use of a BX60 microscope (Olympus Corp., Japan) and commercially available image analysis software (ImagePro).
Statistical comparisons of differences between animal groups were performed by ANOVA (StatView 4.5, Abacus Concepts, Berkeley, CA), and P Ͻ 0.05 after the Bonferroni correction for multiple comparisons were considered significant. Densitometry data were plotted as percent relative density units, with the absorbance in the control group set arbitrarily at 100%.
Results
Mouse SLC-1 cDNA characterization
Using 11 primer pairs spanning nucleotides 313-1084 of the rat SLC-1 sequence (GenBank accession no. AF008650), we were able to amplify six fragments corresponding to the mouse SLC-1. Sequence analysis of these fragments enabled us to use mouse specific primers for 5ЈRACE and 3ЈRACE using a mouse Marathon cDNA library. We obtained two different 5Ј-extending clones and one 3Ј-extending clone that covered the entire coding region of the mouse SLC-1. The full-length nucleotide and deduced amino acid sequence (n ϭ 353) of the mouse MCH-R cDNA are shown in Fig. 1 . At the nucleotide level, the mouse MCH-R cDNA has 92% and 88% homology to the rat and human MCH-R cDNA sequences, respectively. At the amino acid level, the mouse MCH-R has 98% and 96% homology to the rat and human MCH-R, respectively. The genomic organization of the mouse SLC-1 gene seems to parallel that of rat and human (14, 17) , with one intron of approximately 1.2 kb in length spanning the entire coding region (data not shown). In addition, sequence information derived from two different 5Ј-extended clones indicates that those clones represent two different mRNA species that are alternatively spliced, thus implying the presence of an intron in the 5Ј-untranslated region of the gene (data not shown).
MCH-R expression in the mouse brain
In situ hybridization histochemistry analysis of a series of coronal mouse brain sections using an antisense rat SLC-1 riboprobe showed that MCH-R expression is widely distributed in the mouse brain ( Fig. 2A) . Specific hybridization signal is present in cortical areas (orbital, piriform, frontal associative, primary motor, prelimbic, primary somatosensory, posterior parietal associative, retrosplenial, auditory, and visual). In addition, specific hybridization signal was detected in the olfactory nerve layer, olfactory bulb, anterior olfactory nucleus (lateral and external), mitral cell layer (accessory olfactory bulb), olfactory tubercle, nucleus accumbens, and the striatum (caudate nucleus and putamen). Hybridization signal was also present in the hippocampus. In the hypothalamus, hybridization signal was detected in the paraventricular (magnocellular part), dorsomedial, ventromedial, and arcuate nucleus. In the brainstem, hybridization signal was present in the superior colliculus (superficial gray, intermediate gray, intermediate white), inferior colliculus (external cortex, central nucleus), locus coeruleus, and nucleus of the solitary tract. The specificity of the hybridization signal was verified by demonstrating complete absence of hybridization signal to a sense MCH-R RNA probe. By in situ hybridization analysis MCH-R mRNA was also found to be present in the epithelium of the mouse tongue and kidney, whereas sections from heart, liver, and spleen were found to be negative by the same technique (Fig. 2B) . Quantitative RT-PCR analysis of various mouse tissues revealed the highest level of MCH-R expression in brain (Fig. 2C) .
MCH-R mRNA regulation in the mouse brain
Expression of MCH-R mRNA was evaluated by in situ hybridization histochemistry analysis after a 48-h fast. Total brain MCH-R was quantitated using ImageQuant, and a 7-fold increase in expression was noted ( Fig. 3 ; fasted vs. fed animals, P Ͻ 0.05), whereas the pattern of MCH-R expression remained unchanged, as indicated by microscopic examination of the dipped slides (data not shown). When similarly fasted animals were treated with leptin, the fasting-induced up-regulation of MCH-R mRNA was abolished. Leptintreated fasted animals had lower levels of expression than fed animals. Consistent with the hypothesis of leptin-mediated down-regulation of MCH-R expression, brains from leptin-deficient ob/ob mice exhibited a marked global increase in MCH-R expression (Fig. 4A) . Quantitation of signal from several animals revealed that ob/ob mice expressed 3-fold higher levels of MCH-R mRNA compared with control animals (Fig. 4B , ob/ob vs. controls; P Ͻ 0.05). Leptin treatment of ob/ob mice resulted in a significant blunting of MCH-R expression in total mouse brain. Evaluation of the arcuate nucleus by visualization of silver granules on dipped slides revealed a striking difference in the staining intensity in the arcuate hypothalamic nucleus of ob/ob mice compared with controls (Fig. 4C ). More specifically, ob/ob mice showed a 5-fold increase in MCH-R expression in the arcuate nucleus ( Fig. 4C ; ob/ob vs. controls, P Ͻ 0.0010). Our quantitative RT-PCR analysis of MCH-R expression using total brain RNA from various experimental groups, as described above, confirmed the results obtained by in situ hybridization histochemistry analysis, demonstrating a 2.6-fold increase in MCH-R mRNA expression in ob/ob mice compared with controls ( Fig. 5A ; P Ͻ 0.05). Furthermore, ob/ob animals responded to leptin treatment by a significant reduction in MCH-R expression (P Ͻ 0.01). Fasting in ob/ob mice resulted in a moderate (40%) decrease in MCH-R mRNA expression that was borderline statistically significant ( Fig. 5B ; P ϭ 0.048). Using the same experimental approach, we compared MCH-R mRNA levels among MCH-KO animals and their control littermates, and we found these levels to be no different ( Fig. 5C ; P ϭ 0.37). Similar results were obtained by in situ hybridization analysis of MCH-R expression in total brain of MCH-KO and control animals (n ϭ 5/group; data not shown).
Discussion
We used a PCR amplification-based approach in combination with 5Ј-and 3ЈRACE to isolate the full-length cDNA mouse ortholog of the SLC-1. At both the mRNA and protein levels, the transcript exhibits a high degree of conservation among species that is not unexpected, because the peptide structure of MCH (the ligand for SLC-1) is identical in human, rat, and mouse (18). In the mouse, MCH-R was expressed predominantly in the brain, as is also the case for the rat and human transcripts (14, 15, 19, 20) . We as well as other investigators detected SLC-1 mRNA expression in tissues other than brain, such as kidney, testis, white adipose tissue (21), skeletal muscle, and tongue. These observations raise the possibility of a peripheral action for MCH. The presence of MCH-R transcripts and protein in rat white adipose tissue (21) is in support of this hypothesis. Furthermore, in the same system a functional role for MCH in increasing leptin expression and secretion has been demonstrated. Alternatively, those low level (compared with brain) MCH-R transcripts may be of no physiological significance.
Our in situ hybridization analysis in mouse brain slices confirmed that the distribution of the MCH-R mRNA in mouse brain parallels that in the rat brain, involving areas participating in the integration of sensory inputs and the regulation of food intake (20) . The MCH-R mRNA brain expression well parallels the previously known distribution of MCH-immunoreactive neuronal fibers (22) . The presence of MCH-R transcripts in neurons of the olfactory pathway   FIG. 3 . Regulation of brain MCH-R expression by leptin. Serial coronal mouse brain sections were hybridized with a rat MCH-R-specific riboprobe and exposed to film. The autoradiogram corresponding to each brain series was then quantified as described in Materials and Methods. Bars represent MCH-R expression relative to controls (percentage, mean Ϯ SEM). MCH-R expression in control (n ϭ 5), fasted (n ϭ 6), and 48-h fasted mice treated with leptin (1 g/g, ip, twice daily; n ϭ 6). Fasted mice (saline or leptin treated) lost 12.9% and 13.8% of their original weight, respectively. MCH-R expression is increased by fasting and is suppressed by leptin treatment. suggests a role for MCH in olfactory gating and integration mechanisms. Similarly, the detection of MCH-R expression in the nucleus of the solitary tract suggests a role for MCH in gating of gustatory information relayed through this nucleus. We are extending previous observations in rat brain by demonstrating the presence of MCH-R transcripts in the arcuate hypothalamic nucleus, suggesting that MCH may modulate the function of arcuate hypothalamic neurons involved in appetite regulation and energy homeostasis. We are currently working on identifying the arcuate hypothalamic neurons expressing MCH-R.
The negative regulation of MCH-R mRNA by leptin in brain was somewhat unexpected. It has been previously established that orexigenic neuropeptides, such as MCH and NPY, are up-regulated by leptin deficiency and in conditions of low energy stores (2, 3) . Based on these findings, one might expect MCH-R to be down-regulated under conditions of increased expression of its ligand, as is the case for ␣MSH and MC4-R (23). However, this scenario seems not to be true for MCH and its receptor. Surprisingly, MCH-R is up-regulated in two diverse metabolic stages, one of genetic obesity and one of food deprivation, that both have as a common denominator low or absent systemic leptin levels (11, 24) . Furthermore, exogenous leptin administration results in lowering MCH-R expression levels in conditions where those seem to be elevated, as in fasting and in ob/ob mice. Finally, in ob/ob mice that are leptin deficient, MCH-R mRNA levels fail to raise with fasting, as is true for control animals, indicating that the majority of MCH-R mRNA regulation in brain is attributed to leptin effects. Thus, MCH-R appears to be in -FIG. 4 . In situ hybridization histochemistry analysis of MCH-R expression in the ob/ob mouse brain. A, Serial coronal mouse brain sections were hybridized with a rat MCH-R-specific riboprobe and then exposed to film. A representative series from each group of control or ob/ob animals is presented. In the ob/ob brain, MCH-R expression is significantly up-regulated in most areas of the brain. B, MCH-R expression in control (n ϭ 8), ob/ob (n ϭ 7), and leptin-treated ob/ob mice (n ϭ 6). In leptin-deficient ob/ob mice, MCH-R expression is up-regulated compared with that in their control littermates and can be suppressed by exogenously administered leptin. C, After exposure to film, slides were dipped to the photographic emulsion and then developed and microscopically examined. In control animals, nuclei expressing MCH-R are diffusely scattered in the arcuate hypothalamic nucleus. MCH-R expressing neurons in ob/ob mice clustered in the area adjusted to the third ventricle. In addition to changes in the pattern, the levels of MCH-R expression are also increased in ob/ob animals. dependent of its ligand in sensing the organism's metabolic needs as these are communicated by leptin.
Alternatively, one might hypothesize that MCH-R expression is positively regulated by its ligand, as both paradigms analyzed above (fasting and leptin deficiency) are accompanied by increased MCH levels (2) , that can also be downregulated by leptin treatment (Tritos, N. A., and E. MaratosFlier, unpublished observations). The analysis of the MCH-KO animals revealed that this is not the case either, as the absence of the endogenous ligand had little or no effect on MCH-R brain expression.
Based on these data, it is not yet clearly established that the effects of leptin on MCH-R regulation are direct. Systemic corticosterone levels are increased in both fasted C57BL/6J and fed ob/ob mice and are blunted in response to leptin treatment (11) . To exclude the possibility that changes in corticosterone levels have influenced MCH-R mRNA levels in our study, we have examined MCH-R mRNA levels in C57BL/6J mice after dexamethasone treatment, and we have found them to be unchanged (data not shown). The demonstration of colocalization of MCH-R with leptin receptors in various brain areas would further support a direct action of leptin on MCH-R regulation.
In conclusion, in the present study we have cloned the mouse MCH-R, analyzed its brain distribution, and identified it as a central target of leptin's action. In contrast to appetite-regulating hypothalamic peptides, the precise physiological role of their receptors has just started to emerge.
FIG. 5.
Real-time RT-PCR analysis of MCH-R expression and regulation in genetically altered obese and lean animal models. Values (mean Ϯ SEM) are expressed in arbitrary units, and each sample was run in triplicate in a multiplex RT-PCR amplifying the MCH-R and GAPDH. A, Total brain MCH-R expression was assessed in control, ob/ob, and leptin-treated ob/ob animals (n ϭ 4/group). Similarly to results obtained by in situ hybridization analysis, MCH-R mRNA expression was elevated in the brain of ob/ob animals, most likely due to their leptin deficiency, as leptin treatment of the same mice lead to the down-regulation of MCH-R expression. B, Effect of fasting on MCH-R expression in ob/ob mice (n ϭ 4/group). In contrast to normal mice, ob/ob mice failed to respond to short time fasting and weight loss by an increase in MCH-R expression, probably due to their lack of leptin. C, Comparison of MCH-R brain expression in lean MCH-KO mice and controls (n ϭ 6/group). MCH-R expression was unaffected by the lack of its endogenous ligand in the animals that we tested.
